靶点针对疾病信息16(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息
标题
内容
TARGETID
T37539
TARGNAME
B-cell receptor CD22 (CD22)
INDICATI
Approved Lyme borreliosis [ICD-11: 1C1G]
INDICATI
Approved Malignant haematopoietic neoplasm [ICD-11: 2B33]
INDICATI
Approved Mature B-cell leukaemia [ICD-11: 2A82]
INDICATI
Approved Mature B-cell lymphoma [ICD-11: 2A85]
INDICATI
Phase 3 Lupus erythematosus [ICD-11: 4A40]
INDICATI
Phase 1/2 B-cell lymphoma [ICD-11: 2A86]
INDICATI
Phase 1/2 Diffuse large B-cell lymphoma [ICD-11: 2A81]
INDICATI
Phase 1/2 Leukaemia [ICD-11: 2A60-2B33]
INDICATI
Phase 1/2 Lymphoma [ICD-11: 2A80-2A86]
INDICATI
Phase 1/2 Multiple myeloma [ICD-11: 2A83]
INDICATI
Investigative Diabetes mellitus [ICD-11: 5A10]
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3